| Associate Director, US Federal and State Tax Reporting |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Sep 06, 2024 |
| P2P & T&E Specialist (Arabic Speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Jul 05, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Jul 28, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
Aug 05, 2024 |
| Treasury & Cash Management Team Lead |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Aug 12, 2024 |
| Senior Accountant, Tax |
Shanghai (Shanghai) |
China |
Finance |
Corporate |
Audit & Finance |
Aug 29, 2024 |
| Treasury Cash Management Payment Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Oct 16, 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Jun 26, 2024 |
| Manager, Financial Control & Compliance (FC&C) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Oct 06, 2024 |
| Treasury Manager |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Jun 20, 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Oct 22, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Jul 17, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Ningbo (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 24, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 25, 2024 |
| Brand Manager Cardiovascular - Tempo Determinato |
Milano |
Italy |
International |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 25, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chuxiong (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 25, 2024 |
| (高级)区域市场经理 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| Medical Science Liaison - Rheumatology - Ontario |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Research & Development |
Oct 25, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Oct 25, 2024 |
| County Executive |
Zhangzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 08, 2024 |
| Lead/Associate, CX Content Creation |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Oct 20, 2024 |
| Brand Manager |
Dublin (Country President Office (CPO)) |
Ireland |
International |
Innovative Medicines |
Marketing |
Oct 21, 2024 |
| Senior Manager, New Product Planning |
Montreal |
Canada |
International |
Innovative Medicines |
Market Access |
Oct 21, 2024 |
| Manager PSP Operations |
Montreal |
Canada |
International |
Innovative Medicines |
Marketing |
Oct 21, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Oct 21, 2024 |
| Medical Advisor |
Kazakhstan |
Kazakhstan |
International |
Innovative Medicines |
Research & Development |
Oct 21, 2024 |
| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 22, 2024 |
| National Customer Engagement Manager Dermatology |
Amsterdam |
Netherlands |
International |
Innovative Medicines |
Sales |
Oct 22, 2024 |
| Customer Insights & Product Manager - Neurology & Immunology |
Warsaw |
Poland |
International |
Innovative Medicines |
Marketing |
Oct 22, 2024 |
| Executive Assistant |
Taipei |
Taiwan |
International |
Innovative Medicines |
Facilities & Administration |
Oct 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Anqing (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 23, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Oct 23, 2024 |
| Qualification Expert (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Oct 24, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Sep 24, 2024 |
| Sales Value Associate Oncologia&Hematologia |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
Sep 25, 2024 |
| 县域主任(主管) |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Sep 26, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Sep 29, 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
Oct 01, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 10, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 11, 2024 |
| Sales Value Associate - Monterrey Público |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
Oct 11, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 14, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kuerle (Xinjiang Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 16, 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Sales |
Oct 17, 2024 |
| Oncology MSL |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
Oct 18, 2024 |
| Customer Experience and Omnichannel Manager |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Oct 18, 2024 |
| Patient Journey Partner Lead GTx |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
Oct 21, 2024 |